The impact of disease actifity on adverse birth outcomes in a nationwide cohort of woman treated with biologics for chronic inflammatory bowel disease during pregnancy

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalJournal of Crohn's and Colitis Supplements
Volume10
Issue numberSuppl. 1
ISSN1873-9954
Publication statusPublished - 2016

Cite this

@article{1692a1c8b37247dca7acbd06edc881b6,
title = "The impact of disease actifity on adverse birth outcomes in a nationwide cohort of woman treated with biologics for chronic inflammatory bowel disease during pregnancy",
author = "Heidi Kammerlander and Jan Nielsen and Jens Kjeldsen and Torben Knudsen and S. Friedman and N{\o}rg{\aa}rd, {Bente Mertz}",
year = "2016",
language = "English",
volume = "10",
journal = "Journal of Crohn's and Colitis Supplements",
issn = "1873-9954",
publisher = "Elsevier",
number = "Suppl. 1",

}

TY - ABST

T1 - The impact of disease actifity on adverse birth outcomes in a nationwide cohort of woman treated with biologics for chronic inflammatory bowel disease during pregnancy

AU - Kammerlander, Heidi

AU - Nielsen, Jan

AU - Kjeldsen, Jens

AU - Knudsen, Torben

AU - Friedman, S.

AU - Nørgård, Bente Mertz

PY - 2016

Y1 - 2016

M3 - Conference abstract in journal

VL - 10

JO - Journal of Crohn's and Colitis Supplements

JF - Journal of Crohn's and Colitis Supplements

SN - 1873-9954

IS - Suppl. 1

ER -